Cargando…
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
BACKGROUND: Comorbidities are frequent and have been associated with poor quality of life, increased hospitalizations, and mortality in patients with interstitial lung disease (ILD). However, it is unclear how comorbidities lead to these negative outcomes and whether they could influence ILD disease...
Autores principales: | Wong, Alyson W., Lee, Tae Yoon, Johannson, Kerri A., Assayag, Deborah, Morisset, Julie, Fell, Charlene D., Fisher, Jolene H., Shapera, Shane, Gershon, Andrea S., Cox, Gerard, Halayko, Andrew J., Hambly, Nathan, Manganas, Helene, Sadatsafavi, Mohsen, Wilcox, Pearce G., To, Teresa, Marcoux, Veronica, Khalil, Nasreen, Kolb, Martin, Ryerson, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720501/ https://www.ncbi.nlm.nih.gov/pubmed/33287805 http://dx.doi.org/10.1186/s12931-020-01579-7 |
Ejemplares similares
-
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022) -
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
por: Chen, Tao, et al.
Publicado: (2021) -
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Wong, Alyson W., et al.
Publicado: (2020) -
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort
por: Marcoux, Veronica, et al.
Publicado: (2023) -
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
por: Ryerson, Christopher J., et al.
Publicado: (2016)